Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors.
Osvaldo BurasteroLucas A DefelipeGabriel GolaNancy L TateosianElias D LopezCamila Belen MartinenaJuan Pablo ArconMartín Dodes TraianDiana E WetzlerIsabel BentoXavier BarrilJavier RamirezMarcelo A MartiMaria M Garcia-AlaiAdrián G TurjanskiPublished in: Journal of medicinal chemistry (2022)
Computer-aided drug discovery methods play a major role in the development of therapeutically important small molecules, but their performance needs to be improved. Molecular dynamics simulations in mixed solvents are useful in understanding protein-ligand recognition and improving molecular docking predictions. In this work, we used ethanol as a cosolvent to find relevant interactions for ligands toward protein kinase G, an essential protein of Mycobacterium tuberculosis ( Mtb ). We validated the hot spots by screening a database of fragment-like compounds and another one of known kinase inhibitors. Next, we performed a pharmacophore-guided docking simulation and found three low micromolar inhibitors, including one with a novel chemical scaffold that we expanded to four derivative compounds. Binding affinities were characterized by intrinsic fluorescence quenching assays, isothermal titration calorimetry, and the analysis of melting curves. The predicted binding mode was confirmed by X-ray crystallography. Finally, the compounds significantly inhibited the viability of Mtb in infected THP-1 macrophages.
Keyphrases
- mycobacterium tuberculosis
- molecular dynamics simulations
- molecular docking
- protein kinase
- drug discovery
- pulmonary tuberculosis
- binding protein
- high resolution
- protein protein
- small molecule
- dna binding
- energy transfer
- molecular dynamics
- magnetic resonance imaging
- single molecule
- transcription factor
- dual energy
- mass spectrometry
- nucleic acid